Crossmark

miR-338-5p exerts neuroprotective effects in Parkinson’s disease via targeting LRP1

Published Online: 2026-05-09

Published Print: 2026-06

Authors

Zhang, Ni

Cui, Ronghui

Hua, Ye

Lu, Heyue
License Information

Text and Data Mining valid from 2026-05-09

Version of Record valid from 2026-05-09
More Information

Article History

Received: 4 March 2026

Accepted: 24 April 2026

First Online: 9 May 2026

Declarations

:

: The authors declare no competing interests.

Document is current